We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about neuroblastoma, a common childhood cancer, and its impact on kidney health. Understand symptoms, diagnosis, and treatment for parents in India.

Neuroblastoma is a type of cancer that originates from immature nerve cells, specifically those in the sympathetic nervous system. It is a significant concern in pediatric oncology, being the most common cancer in infants and the second most common cancer in children. While neuroblastoma most frequently develops in the adrenal glands, which sit atop the kidneys, it can also, though rarely, start within the kidneys themselves. This article aims to provide parents in India with clear, practical information about neuroblastoma and its potential effects on their child's kidney health, covering symptoms, causes, diagnosis, treatment, and prevention strategies.
Neuroblastoma arises from immature nerve cells, known as neuroblasts. These cells are part of the sympathetic nervous system, which controls involuntary bodily functions like heart rate, blood pressure, and digestion. Neuroblastoma can develop anywhere along this system, but it most commonly starts in the adrenal glands located in the abdomen, just above the kidneys. It can also occur in the neck, chest, or pelvis. The rapid growth and tendency to spread (metastasize) are key characteristics of this cancer.
The relationship between neuroblastoma and the kidneys is multifaceted:
Symptoms of neuroblastoma vary greatly depending on the location and spread of the tumor. When the abdomen is involved, parents might observe:
If a tumor originates in the kidney, early stages might be asymptomatic. However, as it progresses, symptoms can include:
Some neuroblastomas can produce hormones, leading to a condition called paraneoplastic syndrome, which can manifest with a range of symptoms affecting various body systems.
The exact cause of neuroblastoma is not fully understood, but it is believed to involve genetic mutations that occur very early in development. These mutations can cause immature nerve cells to grow uncontrollably. Unlike some other cancers, neuroblastoma is not typically inherited, although rare genetic predispositions exist. Environmental factors are not considered a major cause.
Diagnosing neuroblastoma involves a comprehensive approach:
Treatment for neuroblastoma is tailored to the child's age, the stage of the cancer, and its specific characteristics. Common treatment modalities include:
The prognosis for neuroblastoma varies significantly. Infants with a specific type of advanced neuroblastoma (stage 4S) often have a good outlook, as the tumor may spontaneously regress. For other stages, outcomes depend on factors like age at diagnosis, tumor genetics, and response to treatment.
Since the exact causes are not fully known and it's not typically inherited, there are no definitive ways to prevent neuroblastoma. However, awareness of potential symptoms and seeking prompt medical attention if concerns arise is crucial for early detection, which significantly improves treatment outcomes.
Parents should consult a pediatrician or a specialist if they notice any persistent or concerning symptoms in their child, such as:
Early diagnosis and appropriate management are key to ensuring the best possible outcome for children with neuroblastoma and protecting their long-term kidney health.

Discover 3 subtle signs of mouth cancer often dismissed as minor issues. Learn why early detection is crucial for effective treatment.
April 23, 2026
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026